A comprehensive review on the lipid and pleiotropic effects of pitavastatin.

The 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, or statins, are administered as first line therapy for hypercholesterolemia, both in primary and secondary prevention. There is a growing body of evidence showing that beyond their lipid-lowering effect, statins have a number of additional beneficial properties. Pitavastatin is a unique lipophilic statin with a strong effect on lowering plasma total cholesterol and triacylglycerol. It has been reported to have pleiotropic effects such as decreasing inflammation and oxidative stress, regulating angiogenesis and osteogenesis, improving endothelial function and arterial stiffness, and reducing tumor progression. Based on the available studies considering the risk of statin-associated muscle symptoms it seems to be also the safest statin. The unique lipid and non-lipid effects of pitavastatin make this molecule a particularly interesting option for the management of different human diseases. In this review, we first summarized the lipid effects of pitavastatin and then strive to unravel the diverse pleiotropic effects of this molecule.

• Publication year

  2021

• Venue

  Progress in lipid research

• Publication date

  2021-09-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.plipres.2021.101127PMID 34509516
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of statins on mitochondrial pathways

  2021cited by this paper
• What do we know about the role of lipoprotein(a) in atherogenesis 57 years after its discovery?

  2020cited by this paper
• Inhibiting Airway Smooth Muscle Contraction Using Pitavastatin: A Role for the Mevalonate Pathway in Regulating Cytoskeletal Proteins

  2020cited by this paper
• Injectable calcium phosphate foams for the delivery of Pitavastatin as osteogenic and angiogenic agent.

  2020cited by this paper
• Outcome of pitavastatin versus atorvastatin therapy in patients with hypercholesterolemia at high risk for atherosclerotic cardiovascular disease.

  2020cited by this paper
• Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on ageing: molecular mechanisms.

  2020cited by this paper
• Effects of Pitavastatin on Lipoprotein Subfractions and Oxidized Low-density Lipoprotein in Patients with Atherosclerosis

  2020cited by this paper
• Effects of statins on the biological features of mesenchymal stem cells and therapeutic implications

  2020cited by this paper
• Cholesterol-lowering drug pitavastatin targets lung cancer and angiogenesis via suppressing prenylation-dependent Ras/Raf/MEK and PI3K/Akt/mTOR signaling

  2020cited by this paper
• Statin-induced GGPP depletion blocks macropinocytosis and starves cells with oncogenic defects

  2020cited by this paper
• Anti-Inflammatory Effects of Pitavastatin in Human Airway Structural Cells Occur by a GGPP-Dependent Mechanism

  2020cited by this paper
• Effects of nanoparticle-mediated delivery of pitavastatin on atherosclerotic plaques in ApoE-knockout mice and THP-1-derived macrophages

  2020cited by this paper
• Efficacy and Tolerability of Pitavastatin Versus Pitavastatin/Fenofibrate in High-risk Korean Patients with Mixed Dyslipidemia: A Multicenter, Randomized, Double-blinded, Parallel, Therapeutic Confirmatory Clinical Trial.

  2020cited by this paper
• Simultaneous targeting of mitochondria and monocytes enhances neuroprotection against ischemia–reperfusion injury

  2020cited by this paper
• Effects of statins on brain tumors: a review.

  2020cited by this paper
• Antiviral effects of statins.

  2020cited by this paper
• Comparing different assessments of remnant lipoprotein cholesterol: The very large database of lipids.

  2019cited by this paper
• Screening a library of approved drugs reveals that prednisolone synergizes with pitavastatin to induce ovarian cancer cell death

  2019cited by this paper
• The Effects of Pitavastatin on Nuclear Factor-Kappa B and ICAM-1 in Human Saphenous Vein Graft Endothelial Culture

  2019cited by this paper
• The effects of statins on microglial cells to protect against neurodegenerative disorders: A mechanistic review

  2019cited by this paper
• Statins and Lp(a): do not make perfect the enemy of excellent.

  2019cited by this paper
• Statin-Induced Nitric Oxide Signaling: Mechanisms and Therapeutic Implications

  2019cited by this paper
• Pitavastatin slows tumor progression and alters urine‐derived volatile organic compounds through the mevalonate pathway

  2019cited by this paper
• Characterization of lipoprotein profiles in patients with hypertriglyceridemic Fredrickson-Levy and Lees dyslipidemia phenotypes: the Very Large Database of Lipids Studies 6 and 7

  2019cited by this paper
• Modern prevalence of dysbetalipoproteinemia (Fredrickson-Levy-Lees type III hyperlipoproteinemia)

  2019cited by this paper
• Pitavastatin Exerts Potent Anti-Inflammatory and Immunomodulatory Effects via the Suppression of AP-1 Signal Transduction in Human T Cells

  2019cited by this paper
• Pitavastatin attenuates atherosclerosis by suppressing NF-κB signaling in a high-cholesterol diet plus balloon catheter injury rabbit model.

  2018cited by this paper
• Efficacy and Safety of Pitavastatin in Menopausal Women with Dyslipidemia

  2018cited by this paper
• Higher dietary acid load is associated with higher likelihood of peripheral arterial disease among American adults.

  2018cited by this paper
• Duality of statin action on lipoprotein subpopulations in the mixed dyslipidemia of metabolic syndrome: Quantity vs quality over time and implication of CETP.

  2018cited by this paper
• Pitavastatin treatment induces neuroprotection through the BDNF-TrkB signalling pathway in cultured cerebral neurons after oxygen-glucose deprivation

  2018cited by this paper
• Endothelial Nitric Oxide Synthase-Independent Pleiotropic Effects of Pitavastatin Against Atherogenesis and Limb Ischemia in Mice

  2018cited by this paper
• Improvement of endothelial function by pitavastatin: a meta-analysis

  2018cited by this paper
• Pitavastatin Upregulates Nitric Oxide Synthases in the Kidney of Spontaneously Hypertensive Rats and Wistar–Kyoto Rats

  2018cited by this paper
• High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD)

  2018cited by this paper
• Effects of pitavastatin on walking capacity and CD34+/133+ cell number in patients with peripheral artery disease

  2017cited by this paper
• Anti-asthmatic effect of pitavastatin through aerosol inhalation is associated with CD4+ CD25+ Foxp3+ T cells in an asthma mouse model

  2017cited by this paper
• Pitavastatin nanoparticle-engineered endothelial progenitor cells repair injured vessels

  2017cited by this paper
• Dietary geranylgeraniol can limit the activity of pitavastatin as a potential treatment for drug-resistant ovarian cancer

  2017cited by this paper
• Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trial.

  2017cited by this paper
• Remnant lipoproteins.

  2017cited by this paper
• Targeting colon cancer stem cells with novel blood cholesterol drug pitavastatin.

  2017cited by this paper
• Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in HIV

  2017cited by this paper
• Anticonvulsant and Antioxidant Effects of Pitavastatin Against Pentylenetetrazol-Induced Kindling in Mice

  2017cited by this paper
• Efficacy and safety of pitavastatins in patients with acute myocardial infarction: Livalo in Acute Myocardial Infarction Study (LAMIS) II

  2017cited by this paper
• Pitavastatin and HDL: Effects on plasma levels and function(s).

  2017cited by this paper
• Effects of Pitavastatin on Lipid-rich Carotid Plaques Studied Using High-resolution Magnetic Resonance Imaging.

  2017cited by this paper
• Intranasal pitavastatin attenuates seizures in different experimental models of epilepsy in mice.

  2017cited by this paper
• Greater remnant lipoprotein cholesterol reduction with pitavastatin compared with pravastatin in HIV-infected patients

  2017cited by this paper
• Pitavastatin inhibits proinflammatory cytokines and provides improvement in terms of its motor function in secondary injuries of the spinal cord mouse models

  2017cited by this paper
• Anti‐inflammatory effects of pitavastatin in interleukin‐1&bgr;‐induced SW982 human synovial cells

  2017cited by this paper
• Pitavastatin for lowering lipids.

  2017cited by this paper
• Optimizing Cholesterol Treatment in Patients With Muscle Complaints.

  2017cited by this paper
• Effect of Pitavastatin Treatment on ApoB-48 and Lp-PLA2 in Patients with Metabolic Syndrome: Substudy of PROspective Comparative Clinical Study Evaluating the Efficacy and Safety of PITavastatin in Patients with Metabolic Syndrome

  2016cited by this paper
• Pitavastatin suppressed liver cancer cells in vitro and in vivo

  2016cited by this paper
• Pitavastatin improves glycated hemoglobin in patients with poorly controlled type 2 diabetes

  2016cited by this paper
• Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms.

  2016cited by this paper
• Molecular mechanisms of statin intolerance

  2016cited by this paper
• Stabilization of atherosclerotic plaque by pitavastatin in Watanabe heritable hyperlipidemic rabbits: A serial tissue-characterizing intravascular ultrasound study.

  2016cited by this paper
• Pitavastatin 4 mg Provides Significantly Greater Reduction in Remnant Lipoprotein Cholesterol Compared With Pravastatin 40 mg: Results from the Short-term Phase IV PREVAIL US Trial in Patients With Primary Hyperlipidemia or Mixed Dyslipidemia.

  2016cited by this paper
• Effects of Statin versus the Combination of Ezetimibe plus Statin on Serum Lipid Absorption Markers in Patients with Acute Coronary Syndrome

  2015cited by this paper
• Anti-inflammatory and morphologic effects of pitavastatin on carotid arteries and thoracic aorta evaluated by integrated backscatter trans-esophageal ultrasound and PET/CT: a prospective randomized comparative study with pravastatin (EPICENTRE study)

  2015cited by this paper
• A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations

  2015cited by this paper
• Benefit–risk assessment of pitavastatin for the treatment of hypercholesterolemia in older patients

  2015cited by this paper
• Pitavastatin Reduces Inflammation in Atherosclerotic Plaques in Apolipoprotein E-Deficient Mice with Late Stage Renal Disease

  2015cited by this paper
• Association between statin use and plasma d-dimer levels – A systematic review and meta-analysis of randomized controlled trials

  2015cited by this paper
• Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials.

  2015cited by this paper
• Preconditioning with pitavastatin, an HMG-CoA reductase inhibitor, attenuates C-Jun N-terminal kinase activation in experimental subarachnoid hemorrhage-induced apoptosis

  2015cited by this paper
• The impact of statin therapy on plasma levels of von Willebrand factor antigen

  2015cited by this paper
• Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel

  2015cited by this paper
• Pitavastatin calcium improves endothelial function and delays the progress of atherosclerosis in patients with hypercholesterolemia

  2015cited by this paper
• Pitavastatin attenuates monocyte activation in response to orthopedic implant-derived wear particles by suppressing the NF-κB signaling pathway.

  2015cited by this paper
• Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs

  2014cited by this paper
• Effects of pitavastatin versus atorvastatin on the peripheral endothelial progenitor cells and vascular endothelial growth factor in high-risk patients: a pilot prospective, double-blind, randomized study

  2014cited by this paper
• In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells

  2014cited by this paper
• Combination of Pitavastatin and melatonin shows partial antineoplastic effects in a rat breast carcinoma model.

  2014cited by this paper
• Statins and Neuroprotection: Basic Pharmacology Needed

  2014cited by this paper
• Comparison of Efficacy of Intensive versus Mild Pitavastatin Therapy on Lipid and Inflammation Biomarkers in Hypertensive Patients with Dyslipidemia

  2014cited by this paper
• Comparison of atorvastatin, pitavastatin and rosuvastatin for residual cardiovascular risk using non-fasting blood sampling

  2014cited by this paper
• Comparison of the lipid-lowering effects of pitavastatin 4 mg versus pravastatin 40 mg in adults with primary hyperlipidemia or mixed (combined) dyslipidemia: a Phase IV, prospective, US, multicenter, randomized, double-blind, superiority trial.

  2014cited by this paper
• Atorvastatin and pitavastatin reduce oxidative stress and improve IR/LDL-R signals in Alzheimer’s disease

  2013cited by this paper
• PITAVASTATIN INCREASES HDL PARTICLES WITH PRESERVED ANTI–ATHEROSCLEROTIC PROPERTIES IN DYSLIPIDEMIC PATIENTS

  2013cited by this paper
• Pitavastatin shows greater lipid-lowering efficacy over 12 weeks than pravastatin in elderly patients with primary hypercholesterolaemia or combined (mixed) dyslipidaemia

  2013cited by this paper
• Effects of pitavastatin and atorvastatin on lipoprotein oxidation biomarkers in patients with dyslipidemia.

  2013cited by this paper
• Pitavastatin and Atorvastatin Double-Blind Randomized ComPArative Study among HiGh-Risk Patients, Including ThOse with Type 2 Diabetes Mellitus, in Taiwan (PAPAGO-T Study)

  2013cited by this paper
• Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: the COMPACT-CAD study.

  2013cited by this paper
• Pitavastatin increases HDL particles functionally preserved with cholesterol efflux capacity and antioxidative actions in dyslipidemic patients.

  2013cited by this paper
• Rationale of statin therapy in septic patients.

  2013cited by this paper
• Pitavastatin ameliorated the progression of steatohepatitis in ovariectomized mice fed a high fat and high cholesterol diet

  2013cited by this paper
• Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease?

  2012cited by this paper
• Atorvastatin and pitavastatin reduce senile plaques and inflammatory responses in a mouse model of Alzheimer’s disease

  2012cited by this paper
• Anticonvulsant Effect of Pitavastatin in Mice Induced by Pentylenetetrazole

  2012cited by this paper
• Pitavastatin inhibits hepatic steatosis and fibrosis in non‐alcoholic steatohepatitis model rats

  2011cited by this paper
• Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice.

  2011cited by this paper
• Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): the PATROL trial.

  2011cited by this paper
• Progressive neurovascular disturbances in the cerebral cortex of Alzheimer's disease-model mice: protection by atorvastatin and pitavastatin.

  2011cited by this paper
• Pitavastatin: an overview.

  2011cited by this paper
• Statins Induce the Gene Expression of Apolipoprotein A5 in HepG2 Cells

  2011cited by this paper
• A Large－Scale Survey on Cardio－Cerebrovascular EventsDuring Pitavastatin（LIVALO Tablet）Therapyin Japanese Patients with Hypercholesterolemia―LIVALO Effectiveness and Safety Study Extension（LIVES Study Extension）―

  2011cited by this paper
• Comparison of preventive effect on cardiovascular events with different statins. -The CIRCLE study-.

  2011cited by this paper

• Straight to the core: Intratumoral delivery of pitavastatin and miR-338–5p through lipid nanoparticles inhibits glioblastoma growth

  2026cites this paper
• Correlation of Lp(a), ApoB and oxLDL with Endothelial Damage Reading in Patients with Different Degrees of Coronary Atherosclerosis

  2026cites this paper
• SATURN MRI: study protocol for the statin use in intracerebral hemorrhage patients MRI ancillary study

  2025cites this paper
• Elucidating the Inhibitory Potential of Statins Against Oncogenic c-Met Tyrosine Kinase Through Computational and Cell-based Studies

  2025cites this paper
• Statins: Novel Approaches for the Management of Doxorubicin-Induced Cardiotoxicity—A Literature Review

  2025cites this paper
• Comparison of short-term treatment with atorvastatin versus rosuvastatin for preventing contrast-associated acute kidney injury in patients undergoing coronary angiography/percutaneous coronary intervention: a systematic review and meta-analysis.

  2025cites this paper
• The effect of vitamin E supplementation on serum low-density lipoprotein oxidization: A systematic review and meta-analysis of clinical trials.

  2025cites this paper
• Pitavastatin and resveratrol bio-nanocomplexes against hyperhomocysteinemia-induced atherosclerosis via blocking ferroptosis-related lipid deposition.

  2025cites this paper
• Sepsis: the evolution of molecular pathogenesis concepts and clinical management

  2025cites this paper
• Lipid-targeting antiviral strategies: current state and future perspectives.

  2025cites this paper
• Atorvastatin/rosuvastatin

  2025cites this paper
• Recent advances in the anti-tumor activities of saponins through cholesterol regulation

  2025cites this paper
• Regulatory effects of resveratrol on nitric oxide signaling in cardiovascular diseases

  2025cites this paper
• Statin Treatment Is Associated With a Higher Risk of Carpal Tunnel Syndrome, But not of Ulnar Nerve Entrapment, in Type 2 Diabetes-A Nationwide Register Study.

  2025cites this paper
• The effect of pitavastatin in an ischemic skin flap model in rats

  2024influential citation
• Harnessing anti-inflammatory pathways and macrophage nano delivery to treat inflammatory and fibrotic disorders.

  2024cites this paper
• PD-1-mediated inhibition of T cell activation: Mechanisms and strategies for cancer combination immunotherapy

  2024cites this paper
• Inhibition of cancer cells by Quinoline-Based compounds: A review with mechanistic insights.

  2024cites this paper
• Regulatory effects of statins on Akt signaling for prevention of cancers.

  2024cites this paper
• Targeting PCSK9 as a key player in lipid metabolism: exploiting the therapeutic and biosensing potential of aptamers

  2024cites this paper
• Efficacy of statin therapy in reducing epicardial adipose tissue: a systematic review and meta-analysis

  2024cites this paper
• Advancing personalized medicine with 3D printed combination drug therapies: A comprehensive review of application in various conditions

  2024cites this paper
• The Effect of Statin Therapy on Bone Metabolism Markers and Mineral Density: Aa GRADE-Assessed Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials

  2024cites this paper
• Polymer nanotherapeutics: A promising approach toward microglial inhibition in neurodegenerative diseases

  2024cites this paper
• Pitavastatin attenuates hypercholesterolemia-induced decline in serotonin transporter availability

  2024cites this paper
• Molecular targets in SARS-CoV-2 infection: An update on repurposed drug candidates.

  2024cites this paper
• Old drugs, new tricks: Delivering pitavastatin-loaded nanostructured lipid carriers for glioblastoma treatment.

  2024cites this paper
• Statin Therapy and C-reactive Protein in Patients with Kidney Disease: A Systematic Review and Meta-analysis of Randomized Clinical Trials.

  2024cites this paper
• Effect of Statin Treatment on Lipoprotein-Associated Phospholipase A2 Mass and Activity: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials

  2024cites this paper
• Effect of Phytosterols on Serum Levels of C-Reactive Protein: A Time- and Dose-Response Meta-analysis of Randomized Controlled Trial

  2024cites this paper
• Are we better together? Addressing a combined treatment of pitavastatin and temozolomide for brain cancer.

  2024cites this paper
• 2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)

  2024cites this paper
• Impact of statin therapy on CD40:CD40L signaling: mechanistic insights and therapeutic opportunities

  2024cites this paper
• Regulatory effects of statins on CCL2/CCR2 axis in cardiovascular diseases: new insight into pleiotropic effects of statins

  2024cites this paper
• Effect of statins on arterial wall inflammation as assessed by 18F-FDG PET CT: an updated systematic review and meta-analysis

  2024cites this paper
• Pitavastatin induces caspase‐mediated apoptotic death through oxidative stress and DNA damage in combined with cisplatin in human cervical cancer cell line

  2023cites this paper
• The Effect of Statin Therapy on Serum Uric Acid Levels: A Systematic Review and Meta-Analysis.

  2023cites this paper
• Association of Physical, Psychological and Psychosocial Attributes With Arterial Stiffness in Cardiovascular Disorders: A Systematic Literature Review

  2023cites this paper
• INVESTIGATION OF THE BEHAVIOR OF α-CASEIN UPON BINDING TO FLUVASTATIN AND PITAVASTATIN: A SPECTROSCOPIC STUDY AND MOLECULAR MODELING

  2023cites this paper
• Precision Meets Affordability: A Highly Sensitive HPLC-FLD Technique for Accurate Pitavastatin Quantification in Human Plasma

  2023cites this paper
• PD-1 signaling negatively regulates the common cytokine receptor γ chain via MARCH5-mediated ubiquitination and degradation to suppress anti-tumor immunity

  2023cites this paper
• A look to the past – what has had the biggest impact on lipids in the last four decades? A personal perspective

  2023cites this paper
• Saponins from Chenopodium quinoa willd. husks alleviated high-fat diet-induced hyperlipidaemia via modulating the gut microbiota and multiple metabolic pathways.

  2023cites this paper
• Position paper of the Polish Expert Group on the use of pitavastatin in the treatment of lipid disorders in Poland endorsed by the Polish Lipid Association

  2023cites this paper
• The effect of statin therapy in combination with ezetimibe on circulating C-reactive protein levels: a systematic review and meta-analysis of randomized controlled trials

  2022cites this paper
• Evaluation of miRNA-27a/b expression in patients with familial hypercholesterolemia

  2022cites this paper
• The role of inflammation and the possibilities of inflammation reduction to prevent cardiovascular events

  2022cites this paper
• Multiplex Testing of the Effect of Statins on Disease Severity Risk in COVID-19 Cases.

  2022cites this paper
• Effect of Pravastatin and Simvastatin on the Reduction of Cytochrome C

  2022cites this paper
• Killing the Culprit: Pharmacological Solutions to Get Rid of Cholesterol Crystals.

  2022cites this paper
• Cellular and Molecular Aspects of Managing Familial Hypercholesterolemia: Recent and Emerging Therapeutic Approaches.

  2022cites this paper
• A Multicenter, Randomized, Double-Blind, Active-Controlled, Factorial Design, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of Pitavastatin and Ezetimibe Versus Monotherapy of Pitavastatin in Patients With Primary Hypercholesterolemia.

  2022cites this paper
• Statin Intolerance—We Know Everything, We Know Nothing

  2022cites this paper
• The Effects of Statin Therapy on Oxidized LDL and Its Antibodies: A Systematic Review and Meta-Analysis

  2022cites this paper
• Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022)

  2022cites this paper
• Crosstalk between Statins and Cancer Prevention and Therapy: An Update

  2021cites this paper
• Analysis of Coronary Artery Disease Using Serum/Plasma Data in a Quantum Microrna Language with Artificial Intelligence (MIRAI)

  2021cites this paper
• Cerebrovascular Disease and Statins

  2021cites this paper